Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 21, 2010
Grant Date -
Apr 2, 2009
app pub date -
Dec 18, 2006
filing date -
Dec 20, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; lipid disorders; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; fatty liver disease and cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully